An increase in GzmB+CD8+ T cells was observed upon FKBP12F36V-KRASG12V degradation, suggesting an enhanced cytotoxic T cell–mediated clearance of tumor cells (Figure 5, D and E). The gene discussed is CD8A; the disease is neoplasm.